Cargando…

1565. Antiretroviral Stewardship: Protocol Development and Implementation at an Academic Medical Center.

BACKGROUND: 1.2 million people are living with HIV (PLWH) in the USA. As this population grows older (47% of PLWH were over age 50 in 2018) and more medically complex, the risk of medication errors increases. This population has not been prioritized for stewardship efforts, but experts have called f...

Descripción completa

Detalles Bibliográficos
Autores principales: Bylsma, Tara, Grossman, Katlyn, Vindenes, Tine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678665/
http://dx.doi.org/10.1093/ofid/ofad500.1400
_version_ 1785150416795729920
author Bylsma, Tara
Grossman, Katlyn
Vindenes, Tine
author_facet Bylsma, Tara
Grossman, Katlyn
Vindenes, Tine
author_sort Bylsma, Tara
collection PubMed
description BACKGROUND: 1.2 million people are living with HIV (PLWH) in the USA. As this population grows older (47% of PLWH were over age 50 in 2018) and more medically complex, the risk of medication errors increases. This population has not been prioritized for stewardship efforts, but experts have called for ARV stewardship programs to be developed. We developed a protocol to systematically review patients on ARVs during inpatient admissions to reduce and prevent medication errors, improve patient safety, and improve equity of care for PLWH. METHODS: We implemented a pharmacist-driven intervention over a 3-month period and compared it to usual practice in the 3 months prior to launch. Patients with active ARV prescriptions were identified using a novel automated patient report generated within the EMR. Then, a pharmacist reviewed the ARV regimen and opportunistic infection prophylaxis for accuracy, completeness, potential DDIs or administration issues. A standardized consult note was developed to communicate pharmacist recommendations to the care team. We evaluated qualitative features of the ARV-related interventions and calculated the proportion of hospital days with and without medication errors. RESULTS: The baseline period included 52 patients with an average age of 52 years and LOS of 6.6 days. The intervention period included 60 patients with an average age of 53 years and LOS of 5.4 days. During the intervention, automated pharmacy review led to medication intervention on 49% of patients, compared with 36% of patients in the baseline period. Similarly, the average time to pharmacy intervention decreased from 3 days after admission in the baseline period to 2.5 days in the intervention period. The most common interventions were resuming an ARV regimen and management of DDIs. The most common clinical rationales for interventions were DDIs, acute changes in renal function, and non-formulary medication restrictions. Automated patient identification and pharmacist review reduced the prevalence of medication errors related to ART from 17% of inpatient days to 2% of inpatient days. CONCLUSION: There is a need for ARV stewardship. Expanding, automating, and standardizing these capabilities improved patient safety by reducing medication errors and improving continuity of care in the inpatient setting. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10678665
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106786652023-11-27 1565. Antiretroviral Stewardship: Protocol Development and Implementation at an Academic Medical Center. Bylsma, Tara Grossman, Katlyn Vindenes, Tine Open Forum Infect Dis Abstract BACKGROUND: 1.2 million people are living with HIV (PLWH) in the USA. As this population grows older (47% of PLWH were over age 50 in 2018) and more medically complex, the risk of medication errors increases. This population has not been prioritized for stewardship efforts, but experts have called for ARV stewardship programs to be developed. We developed a protocol to systematically review patients on ARVs during inpatient admissions to reduce and prevent medication errors, improve patient safety, and improve equity of care for PLWH. METHODS: We implemented a pharmacist-driven intervention over a 3-month period and compared it to usual practice in the 3 months prior to launch. Patients with active ARV prescriptions were identified using a novel automated patient report generated within the EMR. Then, a pharmacist reviewed the ARV regimen and opportunistic infection prophylaxis for accuracy, completeness, potential DDIs or administration issues. A standardized consult note was developed to communicate pharmacist recommendations to the care team. We evaluated qualitative features of the ARV-related interventions and calculated the proportion of hospital days with and without medication errors. RESULTS: The baseline period included 52 patients with an average age of 52 years and LOS of 6.6 days. The intervention period included 60 patients with an average age of 53 years and LOS of 5.4 days. During the intervention, automated pharmacy review led to medication intervention on 49% of patients, compared with 36% of patients in the baseline period. Similarly, the average time to pharmacy intervention decreased from 3 days after admission in the baseline period to 2.5 days in the intervention period. The most common interventions were resuming an ARV regimen and management of DDIs. The most common clinical rationales for interventions were DDIs, acute changes in renal function, and non-formulary medication restrictions. Automated patient identification and pharmacist review reduced the prevalence of medication errors related to ART from 17% of inpatient days to 2% of inpatient days. CONCLUSION: There is a need for ARV stewardship. Expanding, automating, and standardizing these capabilities improved patient safety by reducing medication errors and improving continuity of care in the inpatient setting. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10678665/ http://dx.doi.org/10.1093/ofid/ofad500.1400 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Bylsma, Tara
Grossman, Katlyn
Vindenes, Tine
1565. Antiretroviral Stewardship: Protocol Development and Implementation at an Academic Medical Center.
title 1565. Antiretroviral Stewardship: Protocol Development and Implementation at an Academic Medical Center.
title_full 1565. Antiretroviral Stewardship: Protocol Development and Implementation at an Academic Medical Center.
title_fullStr 1565. Antiretroviral Stewardship: Protocol Development and Implementation at an Academic Medical Center.
title_full_unstemmed 1565. Antiretroviral Stewardship: Protocol Development and Implementation at an Academic Medical Center.
title_short 1565. Antiretroviral Stewardship: Protocol Development and Implementation at an Academic Medical Center.
title_sort 1565. antiretroviral stewardship: protocol development and implementation at an academic medical center.
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678665/
http://dx.doi.org/10.1093/ofid/ofad500.1400
work_keys_str_mv AT bylsmatara 1565antiretroviralstewardshipprotocoldevelopmentandimplementationatanacademicmedicalcenter
AT grossmankatlyn 1565antiretroviralstewardshipprotocoldevelopmentandimplementationatanacademicmedicalcenter
AT vindenestine 1565antiretroviralstewardshipprotocoldevelopmentandimplementationatanacademicmedicalcenter